AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Optimizing patient selection for prostate monotherapy
Authors: Lee, AK Schultz, D Renshaw, AA Richie, JP D'Amico, AV
Citation: Ak. Lee et al., Optimizing patient selection for prostate monotherapy, INT J RAD O, 49(3), 2001, pp. 673-677
Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report
Authors: Oh, WK George, DJ Kaufman, DS Moss, K Smith, MR Richie, JP Kantoff, PW
Citation: Wk. Oh et al., Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report, SEMIN ONCOL, 28(4), 2001, pp. 40-44
Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening
Authors: D'Amico, AV Whittington, R Malkowicz, SB Renshaw, AA Tomaszewski, JE Bentley, C Schultz, D Rocha, S Wein, A Richie, JP
Citation: Av. D'Amico et al., Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening, UROLOGY, 58(3), 2001, pp. 406-410
Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era
Authors: D'Amico, AV Whittington, R Malkowicz, SB Weinstein, M Tomaszewski, JE Schultz, D Rhude, M Rocha, S Wein, A Richie, JP
Citation: Av. D'Amico et al., Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era, J UROL, 166(6), 2001, pp. 2185-2188
Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer
Authors: D'Amico, AV Wu, YH Chen, MH Nash, M Renshaw, AA Richie, JP
Citation: Av. D'Amico et al., Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer, J UROL, 165(1), 2001, pp. 126-129
Heparin-binding epidermal growth factor-like growth factor is an autocrinemediator of human prostate stromal cell growth in vitro
Authors: Duque, JL Adam, RM Mullen, JS Lin, JQ Richie, JP Freeman, MR
Citation: Jl. Duque et al., Heparin-binding epidermal growth factor-like growth factor is an autocrinemediator of human prostate stromal cell growth in vitro, J UROL, 165(1), 2001, pp. 284-288
Caveolin-1 interacts with androgen receptor - A positive modulator of androgen receptor mediated transactivation
Authors: Lu, ML Schneider, MC Zheng, YX Zhang, XB Richie, JP
Citation: Ml. Lu et al., Caveolin-1 interacts with androgen receptor - A positive modulator of androgen receptor mediated transactivation, J BIOL CHEM, 276(16), 2001, pp. 13442-13451
Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection
Authors: Liu, BCS LaRose, I Weinstein, LJ Ahn, M Weinstein, MH Richie, JP
Citation: Bcs. Liu et al., Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection, CANCER, 92(7), 2001, pp. 1943-1948
Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer
Authors: D'Amico, AV Whittington, R Malkowicz, SB Schultz, D Silver, B Henry, L Hurwitz, M Kaplan, I Beard, CJ Tomaszewski, JE Renshaw, AA Wein, A Richie, JP
Citation: Av. D'Amico et al., Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer, PROSTATE C, 3(4), 2000, pp. 259-264
Clinical utility of percent-positive prostate biopsies in. predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer
Authors: D'Amico, AV Whittington, R Malkowicz, SB Schultz, D Silver, B Henry, L Hurwitz, M Kaplan, I Beard, CJ Tomaszewski, JE Renshaw, AA Wein, A Richie, JP
Citation: Av. D'Amico et al., Clinical utility of percent-positive prostate biopsies in. predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer, MOL UROL, 4(3), 2000, pp. 171-175
Urinary diversion: The patient's choice
Authors: Richie, JP
Citation: Jp. Richie, Urinary diversion: The patient's choice, ANN SURG O, 7(1), 2000, pp. 1-1
Role of polymorphisms in codons 143 and 160 of the O-6-alkylguanine DNA alkyltransferase gene in lung cancer risk
Authors: Kaur, TB Travaline, JM Gaughan, JP Richie, JP Stellman, SD Lazarus, P
Citation: Tb. Kaur et al., Role of polymorphisms in codons 143 and 160 of the O-6-alkylguanine DNA alkyltransferase gene in lung cancer risk, CANC EPID B, 9(3), 2000, pp. 339-342
Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians
Authors: Park, JY Muscat, JE Kaur, T Schantz, SP Stern, JC Richie, JP Lazarus, P
Citation: Jy. Park et al., Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians, PHARMACOGEN, 10(2), 2000, pp. 123-131
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
Authors: D'Amico, AV Whittington, R Malkowicz, SB Schultz, D Fondurulia, J Chen, MH Tomaszewski, JE Renshaw, AA Wein, A Richie, JP
Citation: Av. D'Amico et al., Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer, J CL ONCOL, 18(6), 2000, pp. 1164-1172
Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials
Authors: D'Amico, AV Whittington, R Malkowicz, SB Wu, YH Chen, MH Hurwitz, M Kantoff, PW Tomaszewski, JE Renshaw, AA Wein, A Richie, JP
Citation: Av. D'Amico et al., Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials, J CL ONCOL, 18(18), 2000, pp. 3240-3246
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
Authors: Catalona, WJ Southwick, PC Slawin, KM Partin, AW Brawer, MK Flanigan, RC Patel, A Richie, JP Walsh, PC Scardino, PT Lange, PH Gasior, GH Loveland, KG Bray, KR
Citation: Wj. Catalona et al., Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging, UROLOGY, 56(2), 2000, pp. 255-260
Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: A preliminary study
Authors: Olumi, AF Richie, JP Schultz, DJ D'Amico, AV
Citation: Af. Olumi et al., Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: A preliminary study, UROLOGY, 56(2), 2000, pp. 273-277
Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland
Authors: D'Amico, AV Weinstein, M Li, XD Richie, JP Fujimoto, J
Citation: Av. D'Amico et al., Optical coherence tomography as a method for identifying benign and malignant microscopic structures in the prostate gland, UROLOGY, 55(5), 2000, pp. 783-787
Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial
Authors: Catalona, WJ Partin, AW Slawin, KM Naughton, CK Brawer, MK Flanigan, RC Richie, JP Patel, A Walsh, PC Scardino, PT Lange, PH deKernion, JB Southwick, PC Loveland, KG Parson, RE Gasior, GH
Citation: Wj. Catalona et al., Percentage of free PSA in black versus white men for detection and stagingof prostate cancer: A prospective multicenter clinical trial, UROLOGY, 55(3), 2000, pp. 372-376
Smoking and alcohol use may be risk factors for poorer outcome in patientswith clear cell renal carcinoma
Authors: Oh, WK Manola, J Renshaw, AA Brodkin, D Loughlin, KR Richie, JP Shapiro, CL Kantoff, PW
Citation: Wk. Oh et al., Smoking and alcohol use may be risk factors for poorer outcome in patientswith clear cell renal carcinoma, UROLOGY, 55(1), 2000, pp. 31-35
Glutathione monoethyl ester protects against glutathione deficiencies due to aging and acetaminophen in mice
Authors: Chen, TS Richie, JP Nagasawa, HT Lang, CA
Citation: Ts. Chen et al., Glutathione monoethyl ester protects against glutathione deficiencies due to aging and acetaminophen in mice, MECH AGE D, 120(1-3), 2000, pp. 127-139
Transperineal magnetic resonance image guided prostate biopsy
Authors: D'Amico, AV Tempany, CM Cormack, R Hata, N Jinzaki, M Tuncali, K Weinstein, M Richie, JP
Citation: Av. D'Amico et al., Transperineal magnetic resonance image guided prostate biopsy, J UROL, 164(2), 2000, pp. 385-387
Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor - Comment
Authors: Richie, JP
Citation: Jp. Richie, Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor - Comment, J UROL, 163(6), 2000, pp. 1786-1787
Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors
Authors: D'Amico, AV Schultz, D Schneider, L Hurwitz, M Kantoff, PW Richie, JP
Citation: Av. D'Amico et al., Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors, J UROL, 163(6), 2000, pp. 1797-1799
Angiosarcoma arising in a testicular teratoma
Authors: Steele, GS Clancy, TE Datta, MW Weinstein, M Richie, JP
Citation: Gs. Steele et al., Angiosarcoma arising in a testicular teratoma, J UROL, 163(6), 2000, pp. 1872-1873
Risultati: 1-25 | 26-43